Back
AbbVie Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
40
ABBV
AbbVie
Last Price:
173.21
Seasonality Move:
3.38%
Sell
40
SRPT
Sarepta Therapeutics
Last Price:
124.56
Seasonality Move:
11.15%
Sell
40
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $174.37. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $125.39. The Score for SRPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $125.39
The current trend is moderately bullish and SRPT is experiencing slight selling pressure.
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.55 | Sell |
| Relative Strength Index (14 RSI): | 39.34 | Sell |
| Chaikin Money Flow: | -4801623 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (167.97 - 187.55) | Sell |
| Bollinger Bands (100): | (179.27 - 198.19) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.91 | Buy |
| Relative Strength Index (14 RSI): | 52.6 | Buy |
| Chaikin Money Flow: | -148826 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (110.97 - 129.63) | Buy |
| Bollinger Bands (100): | (118.88 - 138.48) | Sell |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 177.34 | Sell |
| 20-day SMA: | 174.86 | Sell |
| 50-day SMA: | 185.9 | Sell |
| 200-day SMA: | 178.97 | Sell |
| 8-day EMA: | 176.55 | Sell |
| 20-day EMA: | 178.43 | Sell |
| 50-day EMA: | 182.97 | Sell |
| 200-day EMA: | 178.57 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 127 | Sell |
| 20-day SMA: | 120.27 | Buy |
| 50-day SMA: | 122.59 | Buy |
| 200-day SMA: | 129.86 | Sell |
| 8-day EMA: | 126.45 | Sell |
| 20-day EMA: | 124.05 | Buy |
| 50-day EMA: | 124.06 | Buy |
| 200-day EMA: | 126.23 | Sell |
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.23 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.77 per share, and an increase next year of $7.82 per share.
AbbVie Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||